<DOC>
	<DOCNO>NCT01972906</DOCNO>
	<brief_summary>Hypothesis : Moxibustion effective manage primary dysmenorrhea . Aim : To attest effectiveness safety moxibustion primary dysmenorrhea . Design : A randomized control trial . 152 participant include . Two arm : moxibustion treatment group ibuprofen control group .</brief_summary>
	<brief_title>Moxibustion Primary Dysmenorrhea</brief_title>
	<detailed_description>There convince evidence efficacy moxibustion primary dysmenorrhea , due low methodologic quality small sample size . The investigator design random clinical trial investigates effectiveness moxibustion treat primary dysmenorrhea , purpose study provide research base moxibustion efficacy . The investigator also examine acceptability adverse effect associate use moxibustion .</detailed_description>
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Clinical diagnosis Guidelines Primary dysmenorrhea clinical Society Obstetricians Gynaecologists Canada Menstrual cycle regular ( 28±7 ) day Syndrome differentiation Traditional Chinese Medicine : Congealing colddamp Qistagnation blood stasis Mean value ≥40mm last 3 month Informed consent form must sign patient lineal relative Patients secondary dysmenorrhea , cause endometriosis , pelvic inflammation , myoma uterus Patients unconscious psychotic Patients serious primary illness disease cardiovascular , liver , renal , gastrointestinal , hematological system Patients take prostaglandin synthetase inhibitor ( PGSI ) 2 week inclusion Pregnant woman woman lactation</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>moxibustion</keyword>
	<keyword>primary dysmenorrhea</keyword>
</DOC>